Position in NEO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$924,699
+$803,571 QoQ
Shares Held
63,379
+515.3% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#95
of 265 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $37,165,403 across 11 Diagnostics & Research names. NEO ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
28,360 | $14,218,569 | |
| 2 | ILMN |
Illumina, Inc.
|
34,357 | $6,040,991 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
4,141 | $5,290,168 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
26,115 | $5,045,940 | |
| 5 | GH |
Guardant Health, Inc.
|
17,130 | $2,570,013 | |
| 6 | QGEN |
Qiagen N.V.
|
36,400 | $1,423,240 | |
| 7 | NEO |
Neogenomics Inc
This page
|
63,379 | $924,699 | |
| 8 | VCYT |
Veracyte, Inc.
|
9,200 | $540,316 |
All Filings in NEO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $924,699 | 63,379 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $121,128 | 10,300 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $428,512 | 58,620 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $744,917 | 78,495 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $375,977 | 25,490 | Shares | Sole | 2024-11-12 | |
| 2023-09-30 | $133,036 | 10,816 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||